These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 8430678

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of Imipenem/Cilastatin Burn Intensive Care Unit Patients Undergoing High-Dose Continuous Venovenous Hemofiltration.
    Boucher BA, Hudson JQ, Hill DM, Swanson JM, Wood GC, Laizure SC, Arnold-Ross A, Hu ZY, Hickerson WL.
    Pharmacotherapy; 2016 Dec; 36(12):1229-1237. PubMed ID: 27862103
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Vancomycin pharmacokinetics in acute renal failure: preservation of nonrenal clearance.
    Macias WL, Mueller BA, Scarim SK.
    Clin Pharmacol Ther; 1991 Dec; 50(6):688-94. PubMed ID: 1752113
    [Abstract] [Full Text] [Related]

  • 7. Using imipenem and cilastatin during continuous renal replacement therapy.
    Cotton A, Franklin BD, Brett S, Holmes A.
    Pharm World Sci; 2005 Oct; 27(5):371-5. PubMed ID: 16341743
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Single-dose kinetics of imipenem/cilastatin during continuous arteriovenous haemofiltration in intensive care patients.
    Keller E, Fecht H, Böhler J, Schollmeyer P.
    Nephrol Dial Transplant; 1989 Oct; 4(7):640-5. PubMed ID: 2510062
    [Abstract] [Full Text] [Related]

  • 10. Imipenem/cilastin dosage during acute renal failure and hemofiltration.
    Dehne MG, Kroh UF.
    Intensive Care Med; 1995 Oct; 21(10):863. PubMed ID: 8557879
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration.
    Tegeder I, Neumann F, Bremer F, Brune K, Lötsch J, Geisslinger G.
    Clin Pharmacol Ther; 1999 Jan; 65(1):50-7. PubMed ID: 9951430
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of imipenem/cilastatin during continuous arteriovenous hemofiltration.
    Przechera M, Bengel D, Risler T.
    Contrib Nephrol; 1991 Jan; 93():131-4. PubMed ID: 1802563
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Clinical pharmacokinetics of an imipenem-cilastatin combination].
    Singlas E.
    Presse Med; 1990 Apr 04; 19(13):598-605. PubMed ID: 2139939
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis.
    Joy MS, Matzke GR, Frye RF, Palevsky PM.
    Am J Kidney Dis; 1998 Jun 04; 31(6):1019-27. PubMed ID: 9631848
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Imipenem pharmacokinetics in patients with burns.
    Boucher BA, Hickerson WL, Kuhl DA, Bombassaro AM, Jaresko GS.
    Clin Pharmacol Ther; 1990 Aug 04; 48(2):130-7. PubMed ID: 2379384
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.